Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Elevated blood pressure ups retinal vascular occlusion risk
Individuals with high blood pressure (BP), stage 1 hypertension, and stage 2 hypertension are at greater risk of retinal vascular occlusion relative to those with normal BP, as reported in a study.
Elevated blood pressure ups retinal vascular occlusion risk
05 Feb 2023Dupilumab yields rapid, lasting improvement in erythrodermic atopic dermatitis
Treatment with dupilumab helps improve the signs and symptoms of erythrodermic atopic dermatitis, with the improvements occurring as early as the first week and being sustained over time, according to a study. The drug has an acceptable safety profile.
Dupilumab yields rapid, lasting improvement in erythrodermic atopic dermatitis
04 Feb 2023Hormone therapies up ILD events in men with prostate cancer
Hormone therapy drugs, such as bicalutamide, flutamide, nilutamide, goserelin, degarelix, and apalutamide, appear to increase the likelihood of developing interstitial lung disease (ILD) events in patients with prostate cancer, reports a study.
Hormone therapies up ILD events in men with prostate cancer
04 Feb 2023Does molnupiravir improve outcomes in vaccinated COVID-19 patients?
The addition of molnupiravir to usual care does not reduce hospitalization or death in vaccinated, community-dwelling individuals at high risk of serious outcomes of COVID-19, results of the UK-based PANORAMIC trial showed. However, it may provide other benefits such as reducing time to recovery.
Does molnupiravir improve outcomes in vaccinated COVID-19 patients?
03 Feb 2023Prebiotic supplementation beneficial in mild to moderate ulcerative colitis
Oral supplementation with 1-kestose in patients with mild to moderate ulcerative colitis helps modulate the gut microbiome, which in turn contributes to clinical improvement, as reported in a study.
Prebiotic supplementation beneficial in mild to moderate ulcerative colitis
03 Feb 2023Add-on bevacizumab ups hypertension risk in CRC patients
The addition of bevacizumab (BVZ) to the standard regimen for the treatment of advanced colorectal cancer (CRC) appears to increase the risk of cardiovascular events, suggest the results of a meta-analysis presented at the recent ASCO Gastrointestinal Cancers Symposium (ASCO GI 2023).
Add-on bevacizumab ups hypertension risk in CRC patients
03 Feb 2023Is hypofractionated better than conventionally fractionated RT for stage I NSCLC?
Hypofractionated radiotherapy (HFRT) is not superior to conventionally fractionated radiotherapy (CFRT) in providing survival benefits to patients with stage I nonsmall cell lung cancer (NSCLC), but HFRT is preferable due to its convenience and lower costs, according to a study.